Advertisement
Advertisement

ZLAB

ZLAB logo

Zai Lab Limited - ADR

19.50
USD
Sponsored
+0.50
+2.65%
Jul 01, 13:10 UTC -4
Open

Zai Lab Limited - ADR Profile

About

Zai Lab Ltd is a biopharmaceutical company. It focused on medicines for cancer, autoimmune and infectious diseases primarily in China. The company's product pipeline consists of ZL-2306, ZL-2401, ZL-2301, ZL-3101, ZL-2302 and ZL-1101 which are in clinical stage. Zai Lab Ltd is based in Pudong, China.

Info & Links

CEO

Samantha (Ying) Du

Headquarters

899 Halei Road Building B, Pudong
Shanghai, F4 201203, CHINA

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

www.zailaboratory.com

Auditor

KPMG LLP

Share holders

11

Employees

1,784

Zai Lab Limited - ADR Statistics

Valuation Measures

Market Capitalization2

2.20B

Enterprise Value

1.66B

Enterprise Value/EBITDA(ttm)

-7.16

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

5.08

Price to Book(mrq)

3.25

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

58.79%

Operating Margin(ttm)

-38.15%

Profit Margin(ttm)

-38.25%

Return on Equity(ttm)

-22.81%

Return on Invested Capital(ttm)

-22.90%

Return on Assets(ttm)

-15.04%

Income Statement

Revenue(ttm)

453.28M

Revenue Per Share(ttm)

4.03

Gross Profit(ttm)

262.51M

EBITDA(ttm)3

-232.41M

Net Income Available to Common(ttm)

-178.12M

Diluted EPS(ttm)

-1.61

Share Statistics

Beta (5Y Monthly)

0.86

52-Week Change

-44.23%

S&P 500 52-Week Change

21.12%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

112.35M

Dividend Yield

0.00%

Float4

107.22M

% Held by Insiders

4.96%

% Held by Institutions

41.65%

Balance Sheet

Total Cash(mrq)

761.32M

Total Cash Per Share(mrq)

6.78

Total Debt(mrq)

213.82M

Total Debt/Equity(mrq)

28.59%

Current Ratio(mrq)

2.45%

Quick Ratio(mrq)

2.27%

Book Value Per Share(mrq)

6.47

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.38

Free Cash Flow(ytd)

-158.80M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement